Page last updated: 2024-09-04

ezetimibe and Amyloid Deposits

ezetimibe has been researched along with Amyloid Deposits in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chitose, T; Fujisue, K; Harada-Shiba, M; Hokimoto, S; Hori, M; Izumiya, Y; Kaikita, K; Kajiwara, I; Nagamatsu, S; Ogawa, H; Ono, T; Sakamoto, K; Shirahama, R; Sueta, D; Takashio, S; Tsujita, K; Yamamoto, E	1

Other Studies

1 other study(ies) available for ezetimibe and Amyloid Deposits

Article	Year
Coronary Artery Plaque Regression by a PCSK9 Antibody and Rosuvastatin in Double-heterozygous Familial Hypercholesterolemia with an LDL Receptor Mutation and a PCSK9 V4I Mutation. Internal medicine (Tokyo, Japan), 2018, Volume: 57, Issue:24 Topics: Acute Coronary Syndrome; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Anticholesteremic Agents; Cholesterol, LDL; Drug Therapy, Combination; Ezetimibe; Heterozygote; Humans; Hyperlipoproteinemia Type II; Male; Mutation; Plaque, Amyloid; Proprotein Convertase 9; Receptors, LDL; Rosuvastatin Calcium	2018

Article

Year

Coronary Artery Plaque Regression by a PCSK9 Antibody and Rosuvastatin in Double-heterozygous Familial Hypercholesterolemia with an LDL Receptor Mutation and a PCSK9 V4I Mutation.

Internal medicine (Tokyo, Japan), 2018, Volume: 57, Issue:24

Topics: Acute Coronary Syndrome; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Anticholesteremic Agents; Cholesterol, LDL; Drug Therapy, Combination; Ezetimibe; Heterozygote; Humans; Hyperlipoproteinemia Type II; Male; Mutation; Plaque, Amyloid; Proprotein Convertase 9; Receptors, LDL; Rosuvastatin Calcium

2018